Skip to content

Meet us at COP31Read more

Cybin Inc Sustainability Reports

Cybin Inc., operating commercially as Helus Pharma, is a clinical-stage biopharmaceutical company focused on developing psychedelic-based therapeutics and drug delivery systems to treat mental health disorders such as depression and anxiety.

Sector: Manufacturing

Country: Canada

Exchange: NYSE American

LEI: 549300NTYWN4CVYSCN32

FIGI: BBG00HZ0NJ24

5 reports from 2022 to 2026